Aurobindo Pharma Ltd.

NSE: AUROPHARMA | BSE: 524804 | ISIN: INE406A01037 | Industry: Pharmaceuticals
| Mid-range Performer
1185.0000 2.00 (0.17%)
NSE Jan 01, 2026 13:39 PM
Volume: 302.2K
 

1185.00
0.17%
BOB Capital Markets Ltd.
Eugia unit 3 capacity utilization to increase to 60-65% from 50% in Q3FY25. We expect capacity utilisation to rise above 70% in FY26E
Promoters pledged 0.42% of shares in last quarter. Total pledge stands at 17.50% of promoter holdings
More from Aurobindo Pharma Ltd.
Recommended